Latest news
American Fusion Inc. Files Six Additional U.S. Patent Applications And Advances Texatron Fusion Engine Development And Testing - marketscreener.commarketscreener.com · Thu, 06 Aug 2026 16:52:04 GMTAmerican Fusion Expands Texatron Patent Portfolio with Six New U.S. Patent Applications - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 15:00:36 GMTCreative Medical Technology Holdings, Inc. Receives Notice of Allowance for New U.S. Patent Covering Exosome-Based Immunotherapy for Type 1 Diabetes, Deepening IP Protection Across Its MyeloCelz™, CELZ-101 and CELZ-201 Diabetes Platforms - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 13:27:21 GMTExosome application gets U.S. allowance to target Type 1 diabetes autoimmunity - Stock TitanStock Titan · Thu, 06 Aug 2026 13:15:00 GMTAmerican Fusion Inc. (OTC: AMFN) Provides Intellectual Property and Corporate Development Update - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 12:43:58 GMTRisky Business: Patent Term Adjustment in the Post- Forest Era - IPWatchdog.comIPWatchdog.com · Mon, 03 Aug 2026 14:22:04 GMTCNIPA Releases Revised Measures for Administration of Priority Examination of Patents Excluding Foreigners - The National Law ReviewThe National Law Review · Fri, 31 Jul 2026 21:58:46 GMTFacts and figures: patents, trade marks, designs and hearings: 2025 - GOV.UKGOV.UK · Thu, 30 Jul 2026 07:00:00 GMT